{"id":937725,"date":"2026-02-18T07:05:43","date_gmt":"2026-02-18T12:05:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/"},"modified":"2026-02-18T07:05:43","modified_gmt":"2026-02-18T12:05:43","slug":"cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/","title":{"rendered":"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., Feb.  18, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SccgTbQNn5O2xmYBlaPswXkeYrsK5P6m0XQfEcX-k-vjqfClsCTux3ab-3kE0yWYzS1_OQXi7PYNox-BVBPbTGoiolxIY28PA1drTKXjqzsZ3GEvt6LnNyHJNiaV99d9\" rel=\"nofollow\" target=\"_blank\">Cullinan Therapeutics, Inc.<\/a> (Nasdaq: CGEM; \u201cCullinan\u201d), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today announced that Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Citi 2026 Virtual Oncology Leadership Summit on Thursday, February 19, 2026, at 10:00 a.m. ET.<\/p>\n<p>A webcast of the fireside chat will be available under the Events and Presentations section of the Company\u2019s investor relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t28svoQ3oqq1j0HHygVTVaUs2NH736X35xS0nmLU3nENm3YZAmj7sbLGrlmT1CJ1y4BxMShWs3wvdNSrx4PPHt8kOOnrxWMdDWfCUMG_LeJ7kytxHLcri7yZX-m-Q_eSvPbc2a0sL2cxwxijWklaDU547a419P0YiydUV_xOhbI=\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.cullinantherapeutics.com\/events<\/a>.<\/p>\n<p>\n        <strong>About Cullinan Therapeutics<\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SccgTbQNn5O2xmYBlaPswXkeYrsK5P6m0XQfEcX-k-seiY0toxvZe9Wd6PScvUERsd6zXdDalfxBEpU8D13cfnHY4Oa_rrTb2UZBLN7zKbuZO-F3zOedpATgAt5qditX\" rel=\"nofollow\" target=\"_blank\">Cullinan Therapeutics, Inc.<\/a> (Nasdaq: CGEM) is a biopharmaceutical company developing potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. Cullinan pursues promising therapeutic targets while leveraging core expertise in T cell engagers, which are established in oncology and are now advancing into autoimmune diseases. With a clinical-stage pipeline built on a rigorous scientific approach and purposeful innovation, Cullinan is advancing its mission to deliver new standards of care for patients. Learn more about Cullinan at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t28svoQ3oqq1j0HHygVTVR2WW0TwGp1nHWsHzuihH-6UmSo8sCOnFQgw2Gjh2IVbNwZ0BS2DF2HyVAni6qP6GUJtoUabvBdbl48pXMidpRiwGOHzNbJnYaxJ7B9yore1\" rel=\"nofollow\" target=\"_blank\">https:\/\/cullinantherapeutics.com\/<\/a>, and follow Cullinan on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-3H3T2_bSmkDwJ2qUDC3svigLtpBAAWv6Guqis2fUefZt-K_g0De0xrJEP0z_C81YETXrXdiHi7oBhFDWt87GZvydaS-uQsP3M_GCaqQzmI=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nXtCNP3db2yJuCZUSPPTO_2DAYCOkWKKrCImh-VmTfz7V6V3ZbNikzNXKIZ37zIxNisx3svxxhUU5OTtEpVnng==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Nick Smith<br \/>+1 401.241.3516<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uRq9GQk_G4G33rA5gur_xYtwxPjUv7HEcfktsmxv93Is41jVRAe2MAWk0xb_imakVc0m6Fo0i-da7SvPtaJVBCJEwMik1erayjlThUxY4Wc=\" rel=\"nofollow\" target=\"_blank\">nsmith@cullinantx.com<\/a><\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <br \/>Rose Weldon<br \/>+1 215.801.7644<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H6nYQuL2fg8GYNC6B06aYihfgKFnwxa-T8BlWmkPw_WJF5N6bxGusafKlCB1CCjLMCda-ecCuOm8C6aPMBh--mlaB4899jgzQIX0AGSv7nI=\" rel=\"nofollow\" target=\"_blank\">rweldon@cullinantx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODE4ODk5YjktOTFlNC00M2MzLWEzMzItOTg5MGQyZWZiZjM0LTEyMTc0MjYtMjAyNi0wMi0xOC1lbg==\/tiny\/Cullinan-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) &#8212; Cullinan Therapeutics, Inc. (Nasdaq: CGEM; \u201cCullinan\u201d), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today announced that Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Citi 2026 Virtual Oncology Leadership Summit on Thursday, February 19, 2026, at 10:00 a.m. ET. A webcast of the fireside chat will be available under the Events and Presentations section of the Company\u2019s investor relations website at https:\/\/investors.cullinantherapeutics.com\/events. About Cullinan Therapeutics Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company developing potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. Cullinan pursues promising therapeutic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-937725","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) &#8212; Cullinan Therapeutics, Inc. (Nasdaq: CGEM; \u201cCullinan\u201d), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today announced that Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Citi 2026 Virtual Oncology Leadership Summit on Thursday, February 19, 2026, at 10:00 a.m. ET. A webcast of the fireside chat will be available under the Events and Presentations section of the Company\u2019s investor relations website at https:\/\/investors.cullinantherapeutics.com\/events. About Cullinan Therapeutics Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company developing potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. Cullinan pursues promising therapeutic &hellip; Continue reading &quot;Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-18T12:05:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit\",\"datePublished\":\"2026-02-18T12:05:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/\"},\"wordCount\":212,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/\",\"name\":\"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=\",\"datePublished\":\"2026-02-18T12:05:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/","og_locale":"en_US","og_type":"article","og_title":"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) &#8212; Cullinan Therapeutics, Inc. (Nasdaq: CGEM; \u201cCullinan\u201d), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today announced that Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Citi 2026 Virtual Oncology Leadership Summit on Thursday, February 19, 2026, at 10:00 a.m. ET. A webcast of the fireside chat will be available under the Events and Presentations section of the Company\u2019s investor relations website at https:\/\/investors.cullinantherapeutics.com\/events. About Cullinan Therapeutics Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company developing potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. Cullinan pursues promising therapeutic &hellip; Continue reading \"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-18T12:05:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit","datePublished":"2026-02-18T12:05:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/"},"wordCount":212,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/","name":"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=","datePublished":"2026-02-18T12:05:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NjQ4NSM3NDMxMjI2IzIyMDU4NzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-therapeutics-to-participate-in-fireside-chat-at-the-citi-2026-virtual-oncology-leadership-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=937725"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937725\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=937725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=937725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=937725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}